- Lobbying
- Daniel AND Kracov
Lobbying Arrangements Results for 'Daniel Kracov'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Issues related to abuse-resistant drug products. |
PAIN THERAPEUTICS, INC.
|
ARNOLD & PORTER LLP | |||
Details Issues related to antibiotics. |
Medicis Pharmaceutical Corporation
|
ARNOLD & PORTER LLP | |||
Details Issues related to Medicare Part D drug formularies. |
Forest Laboratories, Inc.
Pharmaceutical manufacturer. |
Arnold & Porter LLP | |||
Details Issues related to antibiotic development incentives and drug shortage legislation. |
Astellas Pharma US, Inc.
Pharmaceutical manufacturing and marketing. |
ARNOLD & PORTER LLP | |||
Details Issues related to health care legislation. |
Genentech Inc.
|
Arnold & Porter Kaye Scholer LLP | |||
Details Issues related to biodefense legislation. Issues related to drug safety legislation. Issues related to drug user fee registration. Issues related to healthcare legislation. |
PFIZER, INC.
|
ARNOLD & PORTER LLP | |||
Details The Biodefense and Pandemic Vaccine and Drug Development Act of 2006. |
Biotechnology Industry Organization
Trade association for biotechnology industry. |
Arnold & Porter LLP | |||
Details Issues related to health care legislation. |
Lundbeck, Inc.
|
Arnold & Porter Kaye Scholer LLP | |||
Details Issues related to various healthcare reform and drug pricing. |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
Arnold & Porter Kaye Scholer LLP | |||
Details Issues related to FDA oversight of Investigational New Drugs, including Fecal Microbiota Transplant Products. |
Rebiotix, Inc.
|
ARNOLD & PORTER LLP | |||
Details Issues related to FDA oversight. |
Ipsen Biopharmaceuticals Inc.
|
ARNOLD & PORTER LLP | |||
Details Issues related to antibiotics. |
Medicis Pharmaceutical Corporation
Specialty pharmaceutical company. |
Arnold & Porter LLP | |||
Details Issues related to brain aneurysms and Ellie's Law (H.R. 1648, S. 1999). |
Edge Therapeutics, Inc.
|
Arnold & Porter Kaye Scholer LLP |